TWP
ABBV icon

Treybourne Wealth Planners’s AbbVie ABBV Stock Holding History

Treybourne Wealth Planners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$397K Hold
3,528
– – 0.25% 31
2021
Q1 		$382K Buy
3,528
+117
+3% +$12.5K 0.26% 30
2020
Q4 		$365K Buy
+3,411
New +$328K 0.26% 29

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Treybourne Wealth Planners's ABBV Position: Q2 2021 in Review

Treybourne Wealth Planners held its AbbVie (ABBV) position steady in Q2 2021 at 3,528 shares worth $397K. The position accounts for 0.25% of the portfolio, ranked #31.

Treybourne Wealth Planners first reported a position in ABBV in Q4 2020 and has held it in 3 quarters since. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Treybourne Wealth Planners held 3,528 shares of AbbVie worth $397K as of Q2 2021.
  • Treybourne Wealth Planners left its AbbVie share count unchanged in Q2 2021.
  • AbbVie made up 0.25% of Treybourne Wealth Planners's portfolio in Q2 2021, its #31 holding.
  • Treybourne Wealth Planners first reported a position in AbbVie in Q4 2020 and has held it in 3 quarters since.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Treybourne Wealth Planners's 13F filing for Q2 2021, filed 29 Jul 2021.